Clinicopathologic Predictors of Hypomethylating Agent Failure in Patients with Myelodysplastic Syndromes

被引:0
|
作者
Chien, Kelly S. [1 ]
Urrutia, Samuel [2 ]
Li, Ziyi [3 ]
Kanagal-Shamanna, Rashmi [4 ]
Abdelhakeem, Ahmed [1 ]
Abuasab, Tareq [1 ]
Almanza, Emmanuel [1 ]
Gener-Ricos, Georgina [5 ]
Bataller, Alex [1 ]
Bazinet, Alexandre [1 ]
Montalban-Bravo, Guillermo [1 ]
Short, Nicholas J. [1 ]
Jabbour, Elias [6 ]
Kadia, Tapan M. [1 ]
Ravandi, Farhad [1 ]
Borthakur, Gautam [1 ]
Hammond, Danielle E. [1 ]
Swaminathan, Mahesh [1 ]
Sasaki, Koji [1 ]
Dong, Xiao Qin [1 ]
Pierce, Sherry [1 ]
Kantarjian, Hagop M. [1 ]
Garcia-Manero, Guillermo [6 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA
[4] MD Anderson Canc Ctr, Hematopathol, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
10.1182/blood-2023-182256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Disease Characteristics and Outcomes of Hypomethylating Agent Failure in Patients With Myelodysplastic Syndromes
    Chien, Kelly
    Kim, Kunhwa
    Li, Ziyi
    Shamanna, Rashmi Kanagal
    Ong, Faustine
    Bravo, Guillermo Montalban
    Kadia, Tapan
    Jabbour, Elias
    Pemmaraju, Naveen
    Hammond, Danielle
    Short, Nicholas
    Ravandi, Farhad
    Alvarado, Yesid
    Pierce, Sherry
    Dong, Xiao Qin
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S311 - S311
  • [2] Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure
    Carraway, Hetty E.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 470 - 477
  • [3] Failure of Hypomethylating Agent-Based Therapy in Myelodysplastic Syndromes
    Kadia, Tapan M.
    Jabbour, Elias
    Kantarjian, Hagop
    [J]. SEMINARS IN ONCOLOGY, 2011, 38 (05) : 682 - 692
  • [4] Beyond hypomethylating agents failure in patients with myelodysplastic syndromes
    Zeidan, Amer M.
    Kharfan-Dabaja, Mohamed A.
    Komrokji, Rami S.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2014, 21 (02) : 123 - 130
  • [5] Predictors of hypomethylating agent discontinuation among patients with higher-risk myelodysplastic syndromes.
    Zeidan, Amer Methqal
    Joshi, Namita
    Kale, Hrishikesh
    Wang, Wei-Jhih
    Corman, Shelby
    Hill, Kala
    Salimi, Tehseen
    Epstein, Robert S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Practical Recommendations for Hypomethylating Agent Therapy of Patients With Myelodysplastic Syndromes
    Steensma, David P.
    Stone, Richard M.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (02) : 389 - +
  • [7] A Novel Model to Predict Outcome of Patients with Myelodysplastic Syndromes (MDS) at the Time of Hypomethylating Agent Failure
    Nazha, Aziz
    Komrokji, Rami S.
    Garcia-Manero, Guillermo
    Barnard, John
    Zell, Katrina
    Zimmerman, Cassie
    Al Ali, Najla H.
    Roboz, Gail J.
    Steensma, David P.
    DeZern, Amy E.
    Padron, Eric
    Jabbour, Elias J.
    Greenberg, Molly Dara
    List, Alan F.
    Kantarjian, Hagop M.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    [J]. BLOOD, 2015, 126 (23)
  • [8] Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
    Darbaniyan, Faezeh
    Zheng, Hong
    Kanagal-Shamanna, Rashmi
    Lockyer, Pamela
    Montalban-Bravo, Guillermo
    Estecio, Marcos
    Lu, Yue
    Soltysiak, Kelly A.
    Chien, Kelly S.
    Yang, Hui
    Sasaki, Koji
    Class, Caleb
    Ganan-Gomez, Irene
    Do, Kim-Anh
    Garcia-Manero, Guillermo
    Wei, Yue
    [J]. EXPERIMENTAL HEMATOLOGY, 2022, 115 : 44 - 53
  • [9] Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure
    Patel, Sagar S.
    Sekeres, Mikkael A.
    Nazha, Aziz
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2532 - 2539
  • [10] The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
    Nazha, Aziz
    Komrokji, Rami S.
    Garcia-Manero, Guillermo
    Barnard, John
    Roboz, Gail J.
    Steensma, David P.
    DeZern, Amy E.
    Zell, Katrina
    Zimmerman, Cassie
    Al Ali, Najla
    Jabbour, Elias
    Greenberg, Molly D.
    Kantarjian, Hagop M.
    Maciejewski, Jaroslaw P.
    List, Alan F.
    Sekeres, Mikkael A.
    [J]. HAEMATOLOGICA, 2016, 101 (06) : E224 - E227